Psychometric Validation of the ESAS12-F
Status
Conditions
Treatments
Details and patient eligibility
About
Assessing symptoms of patients with cancer should be a priority for the physicians to improve their quality of life. The Edmonton Symptom Assessment Scale (ESAS) is a common tool, easy to complete and to analyse. Originally, it has been validated in English with 9 common symptoms. But a new version with 12 commons symptoms and some explanations has been created. This modified version has been translated in French, and the transcultural validation has been done. But the psychometreic validation has not been validated yet.
The primary objective is to validate the psychometric properties of this new version in French.
To validate the tool, we will compare the ESAS12-F to the European Organization for research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) which assesses common symptoms for patients with cancer, which is validated in French, but which is longer and more difficult to complete and to analyse. the patient will complete the ESAS 12-F and the EORTC QLQ-C30 at day 1, then the ESAS12-F at day 2, and the ESAS12-F and the EORTC QLQ-C30 at day 7.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- more than 18YO
- with advanced cancer
- followed but the palliative care team of the Centre Hospitalier Lyon Sud
- without any cognitive impairment
- can read and speak French
Exclusion criteria
- cognitive impairment
- bad performance status
- cannot read or speak French
- no advanced cancer
Trial design
200 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal